New Brand Emultech21 September 2017 During the second Emultech Demonstration Day, we launched our new brand. The logo, visual style and website were designed to communicate what we stand for: a professional high tech company, a technology that is dependable, and products that trigger your imagination. |
|
Second Demonstration Day21 September 2017 On 21 September, the second Emultech Demonstration Day was held at the Pivot Park in Oss, the Netherlands. About 20 people came along from different industries to experience the product demonstrations and to learn about this edition’s theme: GMP. BioConnection, as a trusted partner, hosted this 2nd Demonstration Day. |
|
First Demonstration Day6 April 2017 The first Emultech Demonstration Day on Microfluidic Encapsulation was organized in Eindhoven, the Netherlands on 6 April. Over fifty people from industry came along to experience a demonstration of microfluidic encapsulation with the Emultech Lab first hand.
|
|
EmulTech and Avivia Enter Collaboration30 January 2017 The collaboration will combine EmulTech's innovative technology with Avivia's expertise in complex drug reformulation, to deliver solutions for today's increasing request from pharmaceutical companies. Both companies encounter customers with complex product ideas, who are hitting a wall. Whether it being a new product or reformulation product, life cycle management or generics plus. Teaming up with Avivia was a natural step, as EmulTech was looking to strengthen its offering to its customer and Avivia was looking to do the same. |
|
Developing new strategies for cancer drug delivery, in Denmark and at DukeJanuary 12, 2017 Duke MEMS researcher's five-year, $6-million appointment as a Niels Bohr Professor in Odense Denmark creates a vibrant center for research, launches new collaborations back at Duke |
|
Watch our new instruction video of the Emultech D14 november, 2016 Watch our new instruction video of the Emultech D. |
|
2nd Annual Complex Formulations Symposium 2016EmulTech and Eindhoven University of Technology (TU/e) hosted this year´s 2nd Annual Complex Formulations Symposium September 15th, in Eindhoven, the Netherlands. The event was opened and chaired by Carmen van Vilsteren, director of TU/e Strategic Area Health. The goal of this event was to share advancements of new biological and health related technologies, developments and manufacturing. |
|
EmulTech's new cooperation(Dutch)July 5, 2016 Read about EmulTech's new cooperation with Catharina Ziekenhuis Eindhoven and Fontys TNW! |
|
EmulTech featured by Bioencapsulation Research GroupFebruary 10, 2016 Microfluidic encapsulation is used for the development of Sustained Release Microspheres. |
|
EmulTech featured in OnDrugDeliveryJanuary 15, 2016 Ophthalmic drug delivery is a growing field of interest in the drug delivery industry. EmulTech's unique capabilities offer great advantages in the development of ophthalmics! |
|
EmulTech's Youtube ChannelOctober 12, 2015 For your convenience, EmulTech collected and uploaded its movies and animations to the |
|
Poster presentation ECISSeptember 24, 2015 Scale up from single micro droplets to microfluidic scale up production is successful after characterization of single particles to determine the optimal process window. |
|
How to extend your patent lifeJune 24, 2015 EmulTech offers pharmaceutical companies a unique opportunity in life cycle management of originator drug products by providing a platform for Next Generation Drug Product development. |
|
Take process uncertainty out of the equationJune 11, 2015 EmulTech's INFINITY platform provides unique process understanding allowing for high reproducibility in development and during scale up. |
|
Meet EmulTech at AchemaMay 30, 2015 Meet with EmulTech at the Achema event in Frankfurt am Main, Germany. Contact us to schedule an appointment. |
|
INFINITY user base keeps growing!May 15, 2015 Another undisclosed global ophthalmics company has adopted the INFINITY platform for its drug delivery development program. |
|
EmulTech in Bits & Chips and Technisch WeekbladMarch 17, 2015 The magazines Bits & Chips and Technisch Weekblad recently published about EmulTech and the INFINITY platform. Read article Bits and Chips |
|
Ophthalmic Delivery with INFINITYMarch 3, 2015 Drug product developers continue to demand more controlled manufacturing techniques, especially for the most challenging target of drug delivery: the eye. At EmulTech, we experience the growing interest in delivery of active ingredients to the eye, also known as ocular or ophthalmic delivery. |
|
EmulTech in Technisch Weekblad (in Dutch)February 12, 2015 The Dutch technology magazine wrote about EmulTech and the INFINITY platform. |
|
INFINITY adopted by ChemConnectionFebruary 4, 2015 The INFINITY platform has a new user! The Oss-based CRO, ChemConnection, added the unique microfluidic platform to its range of capabilities. |
|
INFINITY pushes scientific boundariesJanuary 28, 2015 EmulTech is proud to announce the University of Antwerp acquired the INFINITY system for a four-year research program to push the boundaries in micro-particle based drug delivery research. |
|
Leading Medtech Company Acquires INFINITY systemJanuary 20, 2015 Leading Medtech Company Acquires INFINITY system for Development of Next-Generation Medical Devices. |
|
EmulTech and SPSE collaboration successful!January 16, 2015 EmulTech launches INFINITY. Extremely precise medicine delivery possible thanks to new type of production machine! |
|
INFINITY launchAugust 28, 2014 EmulTech launches INFINITY on August 28th 2014. Extremely precise medicine delivery possible thanks to new type of production machine! |
|
EmulTech Featured in Developments in Producing MicrospheresApril 17, 2014 Microencapsulation is a promising drug delivery technology in which APIs are encapsulated with a natural or synthetic material that targets delivery by controlling the API's release. |
|
EmulTech in IPT Autumn editionOctober 17, 2013 Microfluidics is recognised as one of the most promising solutions for micro-encapsulation in the pharmaceutical industry, and the micro-channel cross-intersection design is of particular interest. |
|
EmulTech closes investment roundJune 28, 2013 EmulTech has closed its first investment round with the early stage investors InvestInFuture, Midtop and VIP Fund. |
|
EmulTech in C2W (Dutch)December 9, 2012 EmulTech commits microfluidics to produce drug delivery systems. |
|
